Displaying 1 - 6 of 6 for Cancer - Colon/Rectal
  • AMC-088 Study (H-39190)
    • This randomized phase III trial studies imiquimod or fluorouracil to see how well they work compared to observation in treating patients with high-grade anal squamous skin lesions who are human immunodeficiency virus (HIV)-positive.
  • Biospecimen Banking (H-37203)
    • This study obtains samples from HIV-positive and negative patients with HPV-related cancers of the oropharynx, cervix and anus.
  • Locally Advanced Rectal Cancer, NRG-GI002 (H-41594)
    • This randomized phase II trial studies how well veliparib works with combination chemotherapy and radiation therapy in treating patients with rectal cancer that has spread from where it started to nearby tissue or lymph nodes (locally advanced). 
  • PROSPECT Study (H-32928)
    • The purpose of this study is to investigate how well chemotherapy alone compared to chemotherapy plus radiation therapy works in treating patients with rectal cancer undergoing surgery.
  • Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction (H-38885)
    • The purpose of this clinical trial is to study surgery or non-surgical management in treating patients with intra-abdominal cancer and bowel obstruction.
  • TACTASOM Study (H-35425)
    • This study uses special immune system cells called tumor-associated antigen (TAA)-specific cytotoxic T lymphocytes, a new experimental therapy to treat patients with a solid tumor which has come back or has not gone away after treatment.